Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid

Soriano‑Hernandez,Alejandro D.; Madrigal‑Pérez,Daniela; Galvan‑Salazar,Hector R.; Martinez‑Fierro,Margarita L.; Valdez‑Velazquez,Laura L.; Espinoza‑Gómez,Francisco; Vazquez‑Vuelvas,Oscar F.; Olmedo‑Buenrostro,Bertha A.; Guzman‑Esquivel,Jose; Rodriguez‑Sanchez,Iram P.; Lara‑Esqueda,Agustin; Montes‑Galindo,Daniel A.; Delgado‑Enciso,Ivan

doi:10.3892/ol.2015.3580

Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid

Authors:
- Alejandro D. Soriano‑Hernandez
- Daniela Madrigal‑Pérez
- Hector R. Galvan‑Salazar
- Margarita L. Martinez‑Fierro
- Laura L. Valdez‑Velazquez
- Francisco Espinoza‑Gómez
- Oscar F. Vazquez‑Vuelvas
- Bertha A. Olmedo‑Buenrostro
- Jose Guzman‑Esquivel
- Iram P. Rodriguez‑Sanchez
- Agustin Lara‑Esqueda
- Daniel A. Montes‑Galindo
- Ivan Delgado‑Enciso
View Affiliations

Affiliations: School of Medicine, University of Colima, Colima, Colima 28030, Mexico, Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autononous University of Zacatecas, Zacatecas, Zacatecas 98160, Mexico, School of Chemistry, University of Colima, Coquimatlán Colima 28400, Mexico, General Hospital of Zone No. 1, Mexican Institute of Social Security, Colima, Colima 28000, Mexico, Department of Genetics, School of Medicine, Nuevo Leon Autonomous University, Monterrey, Nuevo León 64460, Mexico, Cancerology State Institute, Colima State Health Services, Colima, Colima 28000, Mexico
Published online on: August 7, 2015 https://doi.org/10.3892/ol.2015.3580
Pages: 2574-2578

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Uterine cervical cancer (UCC) is one of the main causes of cancer‑associated mortality in women. Inflammation has been identified as an important component of this neoplasia; in this context, anti‑inflammatory drugs represent possible prophylactic and/or therapeutic alternatives that require further investigation. Anti‑inflammatory drugs are common and each one may exhibit a different antineoplastic effect. As a result, the present study investigated different anti‑inflammatory models of UCC in vitro and in vivo. Celecoxib, sulindac, nimesulide, dexamethasone, meclofenamic acid, flufenamic acid and mefenamic acid were tested in UCC HeLa, VIPA, INBL and SiHa cell lines. The cytotoxicity of the drugs was evaluated in vitro. Celecoxib, sulindac, nimesulide, mefenamic acid and flufenamic acid presented with slight to moderate toxicity (10‑40% of cell death corresponding to 100 µM) in certain cell lines, while meclofenamic acid exhibited significant cytotoxicity in all essayed cell lines (50‑90% of cell death corresponding to 100 µM). The meclofenamic acid was tested in murine models (immunodeficient and immunocompetent) of UCC, which manifested a significant reduction in tumor growth and increased mouse survival. It was demonstrated that of the evaluated anti‑inflammatory drugs, meclofenamic acid was the most cytotoxic, with a significant antitumor effect in murine models. Subsequent studies are necessary to evaluate the clinical utility of this drug.

View Figures

View References

1	Howley P and Lowy D: Papillomaviruses and their replicationFields Virology. Knipe DM and Howley PM: Lippincott Williams & Wilkins; Philadelphia, PA: pp. 2197–2229. 2001
2	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
3	Hold GL and El-omar EM: Genetic aspects of inflammation and cancer. Biochem J. 410:225–235. 2008. View Article : Google Scholar : PubMed/NCBI
4	Vane J: Towards a better aspirin. Nature. 367:215–216. 1994. View Article : Google Scholar : PubMed/NCBI
5	FitzGerald GA and Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 345:433–442. 2001. View Article : Google Scholar : PubMed/NCBI
6	Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC and Seibert K: Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305:479–484. 1995. View Article : Google Scholar : PubMed/NCBI
7	Gruber BM, Bubko I, KrzysztonRussjan J and Anuszewska EL: Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms. Med Sci Monit. 16:BR45–BR51. 2010.PubMed/NCBI
8	Crum C, Muovo G and Lee K: The cervixSternberg S: Diagnostic Surgical Pathology. 3rd. Lippincott Williams & Wilkins; Philadelphia, PA: pp. 2155–2202. 1999
9	Bauman DR, Steckelbroeck S and Penning TM: The roles of Aldo-Keto reductases in steroid hormone action. Drug News Perspect. 17:563–578. 2004. View Article : Google Scholar : PubMed/NCBI
10	Bauman DR, Rudnick SI, Szewczuk LM, et al: Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes. Mol Pharmacol. 67:60–68. 2005. View Article : Google Scholar : PubMed/NCBI
11	Soriano-Hernández AD, Galvan-Salazar HR, Montes-Galindo DA, et al: Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: A preclinical evaluation. Int Urol Nephrol. 44:471–477. 2012. View Article : Google Scholar : PubMed/NCBI
12	Rahbari R, Sheahan T, Modes V, Collier P, Macfarlane C and Badge RM: A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques. 46:277–284. 2009.PubMed/NCBI
13	Watson DM: The Virginian-Pilot: HeLa Cancer cells killed Henrietta Lacks - then made her immortal. http://hamptonroads.com/2010/05/cancer-cells-killed-henrietta-lacks-then-made-her-immortalAccessed. September 17–2014.
14	Kim KM, Song JJ, An JY, Kwon YT and Lee YJ: Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression. J Biol Chem. 280:41047–41056. 2005. View Article : Google Scholar : PubMed/NCBI
15	Blaheta RA, Weich E, Marian D, BereiterHahn J, Jones J, Jonas D, Michaelis M, Doerr HW and Cinatl J Jr: Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells, and extracellular matrix. Neoplasia. 8:807–816. 2006. View Article : Google Scholar : PubMed/NCBI
16	Kim SH, Song SH, Kim SG, Chun KS, Lim SY, Na HK, Kim JW, Surh YJ, Bang YJ and Song YS: Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol. 130:551–560. 2004. View Article : Google Scholar : PubMed/NCBI
17	Al-Nasiry S, Geusens N, Hanssens M, Luyten C and Pijnenborg R: The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod. 22:1304–1309. 2007. View Article : Google Scholar : PubMed/NCBI
18	Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ and Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst. 84:951–957. 1992. View Article : Google Scholar : PubMed/NCBI
19	Koziol JA, Maxwell DA, Fukushima M, Colmerauer ME and Pilch YH: A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. Biometrics. 37:383–390. 1981. View Article : Google Scholar : PubMed/NCBI
20	SAGARPA: Technical specifications for the care and use of laboratory animals of the Mexican Official Standard (NOM-062-ZOO-1999). https://www.fmvz.unam.mx/fmvz/principal/archivos/062ZOO.PDF(In Spanish). Accessed. June 17–2015.
21	Quann EJ, Khwaja F, Zavitz KH and Djakiew D: The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res. 67:3254–3262. 2007. View Article : Google Scholar : PubMed/NCBI
22	Adachi M, Sakamoto H, Kawamura R, Wang W, Imai K and Shinomura Y: Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol Histopathol. 22:437–442. 2007.PubMed/NCBI
23	Sakonlaya D, Tapanadechopone P, Poomkokruk A and Charoenvilaisiri S: Do NSAID's Inhibit growth of precancerous cervical cells in vitro? J Med Assoc Thai. 95:(Suppl 1). S65–S73. 2012.PubMed/NCBI
24	Wang AH, Tian XY, Yu JJ, Mi JQ, Liu H and Wang RF: Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression. J Int Med Res. 40:56–66. 2012. View Article : Google Scholar : PubMed/NCBI
25	Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W and Greven K: Efficacy and Patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys. 69:111–117. 2007. View Article : Google Scholar : PubMed/NCBI